IRIS
LUS, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.880
NA - Nord America 2.848
AS - Asia 314
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 6.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.842
IE - Irlanda 979
UA - Ucraina 418
IT - Italia 403
GB - Regno Unito 383
DE - Germania 240
CN - Cina 184
FR - Francia 135
FI - Finlandia 100
SE - Svezia 81
GR - Grecia 68
TR - Turchia 61
BE - Belgio 29
HU - Ungheria 21
IR - Iran 19
VN - Vietnam 14
IN - India 12
CA - Canada 6
PL - Polonia 5
SG - Singapore 5
HK - Hong Kong 4
NL - Olanda 4
AT - Austria 3
BR - Brasile 3
CH - Svizzera 3
EU - Europa 3
IL - Israele 3
PK - Pakistan 3
AU - Australia 2
ID - Indonesia 2
JP - Giappone 2
KR - Corea 2
NZ - Nuova Zelanda 2
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
NO - Norvegia 1
RS - Serbia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.054
Salva come PNG Salva come JPEG
Città #
Dublin 979
Jacksonville 594
Chandler 586
Princeton 149
Ann Arbor 146
Roxbury 118
Bremen 101
Medford 100
Caserta 87
Beijing 85
Wilmington 59
Woodbridge 58
Boardman 56
Cambridge 56
New York 56
San Mateo 39
Ashburn 31
Brussels 27
Des Moines 24
Norwalk 24
Naples 21
Milan 20
Houston 17
Dong Ket 14
Jinan 14
Nanjing 14
Los Angeles 11
Redwood City 11
Luzzano 10
Mountain View 10
Rome 10
Düsseldorf 9
Auburn Hills 8
Siano 8
Tianjin 8
Napoli 7
Helsinki 6
Taizhou 6
Nanchang 5
Reggio Nell'emilia 5
Seattle 5
Shenyang 5
Wroclaw 5
Zhengzhou 5
Hangzhou 4
Hebei 4
Hyderabad 4
Lanzhou 4
Leawood 4
San Giorgio A Cremano 4
Andover 3
Aversa 3
Central District 3
Changchun 3
Darmstadt 3
Dearborn 3
Fairfield 3
Guangzhou 3
Haikou 3
Karachi 3
Kunming 3
Lappeenranta 3
Ningbo 3
Philadelphia 3
Romentino 3
Sacramento 3
Salerno 3
Venice 3
Vienna 3
Amsterdam 2
Boydton 2
Carrara 2
Cava de' Tirreni 2
Cercola 2
Changsha 2
Chennai 2
Florence 2
Gunzenhausen 2
Lier 2
Limbiate 2
Marcianise 2
Munich 2
Otranto 2
Paris 2
Pescara 2
Porto Alegre 2
Putignano 2
San Valentino Torio 2
Shanghai 2
Solofra 2
Tel Aviv 2
Terni 2
Toronto 2
Turin 2
Wuhan 2
Zanjan 2
Absecon 1
Acibadem 1
Agordo 1
Ancona 1
Totale 3.748
Salva come PNG Salva come JPEG
Nome #
INSOLITO PNEUMOCEFALO IPERTESO DA OSTEOMA DEL SENO FRONTALE 155
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 89
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 89
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients 88
Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro 84
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 83
A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations 75
Biochemical and morphological evidences supporting the hypothesis of a role of Tgase in the pathogeneisi of Chorea-Acanthocytosis 68
Myoplasticity and myoregeneration; from molecular aspects to clinical perspectives 65
Chronic HCV infection and neurological and psychiatric disorders: an overview. 63
Analisi in istofluorescenza di densità e distribuzione dei recettori per ConA e WGA in corso di rigenerazione e re-innervazione nel muscolo scheletrico di ratto ischemizzato e denervato, reversibilmente o irreversibilmente 63
Malattie dei nervi periferici 62
NEURO-DEGENERAZIONE CON ACCUMULO CEREBRALE DI FERRO TIPO 1 (NIBA TIPO1), UNA NUOVA FAMIGLIA CON MALATTIA DI HALLERVORDEN SPATZ A DECORSO CLINICO PROTRATTO 62
Myopathic changes in neurofibromatosis type 1 61
Cecità e diplopia come espressione isolata di metastasi mesencefalica:considerazioni neuroradiologiche neurologiche e neurochirurgiche.A proposito di 2 casi 61
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis 61
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 60
Autoantibodies in multiple sclerosis patients before and during IFN-β1b treatment: Are they correlated with the occurrence of autoimmune diseases? 59
Reperti isto e citopatologici del tutto peculiari riscontrati in un caso familiare di sindrome della spina rigida 59
Retrospective epidemiology of Duchenne muscular dystrophy in Molise 58
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 58
La capacità rigenerativa del muscolo scheletrico danneggiato: studio sperimentale 57
CTG repeat number in the nonaffected allele of myotonic dystrophy patients is not critical for disease expression 56
Are giant axons a pathological marker of charcot-marie-tooth neuropathy type 2E? 56
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 56
Animal model to study factors influencing regeneration and direct innervation or neurotization of skeletal muscle 56
LA NEUROMIELITE OTTICA È UN’ ASSOCIAZIONE SINDROMICA COMUNE A PATOLOGIE ETEROGENEE 56
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 55
Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. 55
CECITÀ E DIPLOPIA COME ESPRESSIONE ISOLATA DI METASTASI MESENCEFALICHE: CONSIDERAZIONI NEURORADIOLOGICHE, NEUROLOGICHE E NEUROCHIRURGICHE A PROPOSITO DI DUE CASI” 55
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 55
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome 54
Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment. 54
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 53
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis 53
Unusual manifestation of vertebral osteoid osteoma: case report 52
[Ambulatory monitoring of arterial pressure in the diagnosis and therapeutic evaluation of dysautonomic diseases: observations in a case of Shy-Drager syndrome] 52
An unusual phenotype of familial motor and sensory neuropathy with morphological features of HMSN1 52
C’È UN GUADAGNO DIAGNOSTICO IN RM DELLE SACNSIONI TARDIVE OPO DOSE TRIPLA DI GADOLINIO NELL’IDENTIFICAZIONE DI PLACCHE ATTIVE DI SCLEROSI MULTIPLA? * Risultati preliminari 52
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 51
Fluctuations of MS births and UV-light exposure. 51
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases 51
A new tRNAHis mutation in the mtDNA results in mitochondrial encephalomyopathy by hampering ATP production 51
CORRELATI CLINICO-STRUMENTALI IN UN CASO DI CREUTZFELD- JACOB A LUNGA SOPRAVVIVENZA. 51
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis 51
Prognostic indicators in pediatric clinically isolated syndrome 51
39. Density and distribution of ConA and WGA receptors determined by histofluorescence analysis during degeneration, regeneration and reinnervation of the rat skeletal muscle following ischemia and reversible or irreversible denervation. , : , 50
Dalla malattia di Schilder alla adrenoleucodistrofia: una breve storia di un secolo di ricerca neuropatologica clinica esemplare 50
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 49
Progressive rubella panencephalitis. Follow-up EEG study of a case 49
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 49
Rasagiline improves sleep disorders in Parkinson's disease 49
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis 49
Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases 48
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. 48
Dalla malattia di Schilder all’adrenoleucodistrofia; una breve storia di un secolo di ricerca neuropatologica clinica esemplare 48
NEURO-DEGENERAZIONE ASSOCIATA A PANTOTENATO- CHINASI (MALATTIA DI HALLERVORDEN – SPATZ) IN UNA FAMIGLIA ITALIANA: CORRELAZIONI CLINICHE,MRI E GENETICHE 47
AZATIOPRINA E INTERFERONE - 1° NEI PAZIENTI CON SCLEROSI MULTIPLA RECIDIVANTE REMITTENTE: INCREMENTO DELL’EFFICACIA DEL TRATTAMENTO COMBINATO. 47
Malattie mono e plurisistemiche 46
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis 46
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders 45
[Unusual histo-cytopathologic findings in a familial case of stiff spine syndrome] 45
Rigenerazione e reinnervazione del muscolo scheletrico di ratto ischemizzato e, reversibilmente o irreversibilmente, denervato: osservazioni in istofluorescenza della densità e distribuzione dei recettori per ConA e WGA 45
Monitoraggio biologico e sorveglianza sanitaria ai lavoratori esposti a bromuro di metile 45
A cluster of progranulin C157KfsX97 mutation in southern Italy- clinical characterization and genetic correlations 45
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate 45
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 44
Histopathological heterogeneity and cytopathological similarity of findings in different muscles of two brothers affected by rigid spine syndrome 44
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 44
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 44
Malattie multisistemiche 43
Muscular regeneration and reinnervation or neurotization in control, preinjured or dystrophic animals 43
Familial idiopatic hyperCKemia: changes of muscle biopsy in 8 cases 43
EFFICACIA E TOLLERABILITÀ DEL TRATTAMENTO A LUNGO TERMINE CON AZATIOPRINA NELLA SCLEROSI MULTIPLA RECIDIVANTE-REMITTENTE: UNO STUDIO PROSPETTICO 40
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 40
Malattia demielizzante in un bambino: contributo diagnostico della RM. 39
Central pontine myelinolisis- case report 39
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study 39
The Italian multiple sclerosis register 39
Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy 38
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 38
Malattie della giunzione neuromuscolare 38
Malattie del muscolo 38
Histochemical, cytochemical and biochemical observations in orthotopic homotransplants of EDL in adult rats 38
Variability of muscle findings in rigid spine syndrome. : , 38
Migraine as possible red flag of PFO presence in suspected demyelinating disease 38
Clinical and Genetic Heterogeneity in a Large Family with Pseudoxanthoma Elasticum: MTHFR and SERPINE1 Variants as Possible Disease Modifiers in Developing Ischemic Stroke 38
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 38
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis 37
Mitochondrial myopathy and Marfan-like clinical pattern 37
Neutralizing antibodies in multiple sclerosis patients treated with 375 microg interferon-beta-1b 36
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis 36
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 36
Hyperckemia in the neuroacanthocytosis: possible tissutal transglutaminase abnormality in skeletal muscle 35
Malattie del nervo periferico 33
Osservazioni istologiche ed istochimiche nell' EDL di ratto adulto ischemizzato e, reversibilmente o irreversibilmente, denervato 33
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 33
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 33
Disability assessment using Google Maps 33
Charcot-Marie-Tooth disease with giant axons: a clinicopathological and genetic entity 32
Totale 5.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201929 0 0 0 0 0 0 0 0 0 0 7 22
2019/2020761 137 127 20 6 122 20 140 27 39 58 48 17
2020/20211.029 185 14 101 55 149 17 131 102 22 122 88 43
2021/20221.112 52 138 14 29 302 10 27 37 37 70 101 295
2022/20232.076 178 36 34 188 247 182 2 136 949 20 60 44
2023/2024588 73 21 50 58 259 62 10 25 23 4 3 0
Totale 6.428